Preoperative care/Catalogs/Beta-blocker evidence table
Jump to navigation
Jump to search
Patients | Intervention | Comparison | Outcome | Results | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Mortality | Stroke | Beta-blocker toxicity | ||||||||
Rx | Control | Rx | Control | Rx | Control | |||||
DECREASE-IV[1] 2009 |
1066 patients * Vascular: <1% * RCRI>2: 0% |
Bisoprolol * Started a median of 34 days preop * Target HR: >50 bpm |
Open label | Mortality at 30 days | cell | cell | cell | cell | cell | cell |
cell | cell | cell | cell | cell | cell | cell | cell | cell | cell | cell |
References
- ↑ 1.0 1.1 Dunkelgrun M, Boersma E, Schouten O, et al. (June 2009). "Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV)". Ann. Surg. 249 (6): 921–6. DOI:10.1097/SLA.0b013e3181a77d00. PMID 19474688. Research Blogging.